Home » Newsletters » BioWorld Science

BioWorld Science

March 20, 2002

View Archived Issues

Neotrofin protects against neurodegeneration in a rat model of Parkinson's disease

Once-weekly antidepressant safe and effective in natural clinical setting

Inhibition of UL70 primase as a promising approach to the treatment of cytomegalovirus infections

QYL-1064 and analogues effective against cytomegalovirus and certain other herpesviruses

UMJD-1369 identified as a potent, early-acting anti-HCMV pyrrolopyrimidine

Results reported in Barcelona for DNA and protein AutoVac HER-2 vaccines

Ezetimibe further improves lipoprotein profiles in statin-treated hypercholesterolemic patients

Compounds that prevent peptide metabolism reported by Sumitomo

Sankyo describes novel immunosuppressants in a recent patent

Steroid sulfatase inhibitors disclosed by Nippon Organon

Scientists at Aventis describe a new series of antidiabetic compounds

Melacure Therapeutics discloses melanocortin receptor ligands and their use

Novel LPS inhibitors synthesized at Mitsubishi Pharma

Ligand reports on 2001 highlights

Inex offers 2001 update

Swiss approval and launch of Tracleer announced

Amersham Health reports good progress in a number of areas during 2001

Zelnorm/Zelmac approved in Canada and Brazil

deCODE completes MediChem acquisition

Health Canada approves expanded label for ProstaScint

Boston Life Sciences initiates phase II study of Altropane for ADHD diagnosis

PowderJect to sell drug business to AlgoRx

PH-50 uptake in animal soft plaque tissue encouraging for early diagnosis of coronary artery disease

Encouraging results emerge from pilot phase III trial of Chronogesic

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...